The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anil Jain
BAJAJHCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anil Champalal Jain, Managing Director and member of the promoter group of Bajaj Healthcare Ltd, has converted 4,55,074 convertible warrants into equity shares on 18 March 2026. As a result, his direct equity holding in the company rose from 14,81,470 shares (4.69%) to 19,36,544 shares (5.75%) of the paid-up share capital. The conversion increased the company's total equity share capital from 3,15,83,252 shares to 3,36,62,661 shares of Rs. 5 each. The shares were allotted by the company upon warrant conversion, not acquired from the open market.
This is a warrant-to-equity conversion that strengthens the promoter's direct equity stake in Bajaj Healthcare by about 1 percentage point. It signals continued promoter confidence through the conversion of a pre-existing commitment, but involves no fresh cash outflow and is unlikely to materially move the stock price.